Browse Category

Artificial Intelligence News 8 December 2025

UiPath (PATH) Stock Soars After First GAAP Profit: Can the AI Automation Rally Last? – December 8, 2025

UiPath (PATH) Stock Soars After First GAAP Profit: Can the AI Automation Rally Last? – December 8, 2025

UiPath Inc. (NYSE: PATH) has quickly moved back onto traders’ radar screens. After delivering its first GAAP‑profitable quarter and raising guidance, the automation specialist’s shares have surged to fresh 52‑week highs and are now trading above where most Wall Street
Booking Holdings (BKNG) Stock on December 8, 2025: Latest Price, Hedge‑Fund Moves, AI Deals and 2026 Forecasts

Booking Holdings (BKNG) Stock on December 8, 2025: Latest Price, Hedge‑Fund Moves, AI Deals and 2026 Forecasts

Booking Holdings Inc. (NASDAQ: BKNG), the parent of Booking.com, Priceline, Agoda, KAYAK and OpenTable, is starting the week of December 8, 2025 trading near the top of its 52‑week range as investors digest a flood of institutional filings, AI‑driven product
Intuit (INTU) Stock on December 8, 2025: AI Momentum, Big-Money Buying and Insider Selling Shape the Outlook

Intuit (INTU) Stock on December 8, 2025: AI Momentum, Big-Money Buying and Insider Selling Shape the Outlook

Published: December 8, 2025 – Not investment advice. Intuit Inc. (NASDAQ: INTU), the company behind TurboTax, QuickBooks, Credit Karma and Mailchimp, is closing out 2025 with a mix of powerful AI‑driven growth, heavy institutional buying, and eye‑catching insider sales that
Recursion Pharmaceuticals (RXRX) Stock Jumps on Positive FAP Trial Data: Latest News, AI Drug Discovery Outlook and Analyst Forecasts

Recursion Pharmaceuticals (RXRX) Stock Jumps on Positive FAP Trial Data: Latest News, AI Drug Discovery Outlook and Analyst Forecasts

Recursion Pharmaceuticals’ stock is back in the spotlight on 8 December 2025 after the company reported encouraging mid‑stage trial results for its AI‑discovered drug REC‑4881 in a rare, cancer‑linked condition called familial adenomatous polyposis (FAP). The news gives investors something
Nvidia (NVDA) Stock on December 8, 2025: CUDA 13.1, Synopsys Deal and SAFE CHIPS Act Steer the Next AI Chapter

Nvidia (NVDA) Stock on December 8, 2025: CUDA 13.1, Synopsys Deal and SAFE CHIPS Act Steer the Next AI Chapter

(for editors) Nvidia stock is trading around $183 on December 8, 2025, as investors digest a massive CUDA 13.1 software update, a $2 billion Synopsys deal, blockbuster Q3 FY26 earnings, and new export-control legislation. Here’s how the latest news and
AppLovin (APP) Stock Surges on AI Momentum: Latest News, Analyst Targets and 2025–2030 Forecasts (December 8, 2025)

AppLovin (APP) Stock Surges on AI Momentum: Latest News, Analyst Targets and 2025–2030 Forecasts (December 8, 2025)

AppLovin Corporation (NASDAQ: APP) has become one of the most talked‑about AI and advertising stocks of 2025. Its Axon AI engine, booming profitability and relentless share price rally have pushed APP firmly into large‑cap territory — and onto the radar
IBM to Acquire Confluent for $11 Billion in All‑Cash Deal to Power Enterprise AI Data Streaming

IBM to Acquire Confluent for $11 Billion in All‑Cash Deal to Power Enterprise AI Data Streaming

December 8, 2025 International Business Machines (IBM) has agreed to acquire data‑streaming specialist Confluent in an all‑cash transaction valued at $11 billion, the latest sign that Big Tech’s AI arms race is shifting from models to the real‑time data infrastructure
Salesforce (CRM) Stock Today: AI ‘Holy Grail’ Hype, Big Fund Moves and Key Levels Before the December 8, 2025 Open

Salesforce (CRM) Stock Today: AI ‘Holy Grail’ Hype, Big Fund Moves and Key Levels Before the December 8, 2025 Open

Salesforce, Inc. (NYSE: CRM) heads into Monday’s U.S. trading session with fresh earnings momentum, a loud new AI narrative, and a flurry of institutional filings hitting the tape this morning. Here’s what traders and long‑term investors need to know about
1 18 19 20 21 22 154
Go toTop